Insider Buying: Artiva Biotherapeutics (NASDAQ:ARTV) Director Purchases 120,582 Shares
MarketBeat
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV - Get Free Report) Director Ra Capital Management, L.P. purchased 120,582 shares of the company's stock in a transaction that occurred on Tuesday, July 21st. The shares were purchased at an average cost of $9.55 per share, for a total transaction of $1,151,558.10. Following the completion of the transaction, the director owned 17,098,479 shares in the company, valued at approximately $163,290,474.45. This represents a 0.71% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.
NASDAQ:ARTV
